Victor P. Micati, MBA, Chairman of the Board of Directors - More than 40 years experience in the pharmaceutical industry. Former Executive VP of Pharmaceutical Group, Pfizer; former member of Board of Directors, Pfizer International; Director, Enzon

David Dantzker, MD, Director - General Partner, Wheatley MedTech Partners LP. Former President of North Shore-LIJ Health System (annual revenue over $3 billion), co-founded the North Shore-LIJ Research Institute.

James Moe, PhD, MBA, Director, President & CEO – More than 20 years experience in academic and industrial R&D in drug discovery, diagnostics and medical devices including Gene-Trak, Vysis, bioMerieux, Mosaic Technologies, Spire Corporation, and Q-RNA

Jack Pasini, MBA, Director, Chief Commercial Officer - Broad global commercial leadership experience during 30 year Pfizer career. Former Vice-President Worldwide Marketing, VP Product Development, and VP Business Intelligence & Planning

Douglas N. Durand, R.Ph., Director - Founder and managing director of Durand Venture Associates, LLC; served as Director of Marketing and Regional Sales at Merck; served as Executive Director of Marketing AstraZeneca/Astra Pharmaceuticals.

Eliot Davidowitz, Ph.D., Chief Scientist - More than 20 years experience in academic research and industrial R&D in drug discovery, platform development at Q-RNA

Back to Company Overview